Dietmar Berger

Insider Reports History

Location
C/O Atara Biotherapeutics, Inc., 611 Gateway Boulevard, Suite 900, South San Francisco, CA
Signature
/s/ Edward S. Son by Power of Attorney for Dietmar Berger
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dietmar Berger:

Stock Role Class Num Shares Value Price $ Report Date Ownership
GILEAD SCIENCES, INC. Chief Medical Officer Restricted Stock Unit 57.5K $5.99M $104.09 Mar 10, 2025 Direct
Arcus Biosciences, Inc. Director Common Stock 0 $0 $15.00 Feb 6, 2025 Direct
GILEAD SCIENCES, INC. Chief Medical Officer Non-qualified Stock Option (Right to Buy) 37.7K Mar 10, 2025 Direct

Insider Reports Filed by Dietmar Berger

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GILD GILEAD SCIENCES, INC. Mar 10, 2025 2 $0 4 Mar 12, 2025 Chief Medical Officer
RCUS Arcus Biosciences, Inc. Feb 6, 2025 0 $0 3 Feb 10, 2025 Director
GILD GILEAD SCIENCES, INC. Jan 2, 2025 1 $0 4 Jan 3, 2025 Chief Medical Officer
GILD GILEAD SCIENCES, INC. Jan 2, 2025 0 $0 3 Jan 3, 2025 Chief Medical Officer